Medicus Pharma Reports Second Quarter 2026 Financial Results and Provides Corporate Update | MDCX Stock NewsStockTitan·Aug 12 at 02:00 PMMDCX+3.46%
Healthcare Divergence and Energy's Quiet Boom: The Q2 2026 OverhaulGlobal Report·Aug 8 at 09:21 AMTDOC+3.19%SAN+2.57%
Micro-Cap Survival Tactics: Funding AI Pivots and Selling Crypto to SurviveGlobal Report·Aug 7 at 09:19 AMPAYS+1.09%VRSK-3.18%
Mid-Cap US Equities Diverge: Charles River Raises Forecast as Tech Firms Weigh RestructuringGlobal Report·Aug 6 at 09:15 AMECL-0.12%SWVL+32.64%
Medicus Pharma Appoints Dr. Faisal Mehmud as Chief Executive Officer of Antev Limited, United KingdomUnusual Whales·Aug 3 at 11:31 AMMDCX+3.46%
12 Health Care Stocks Moving In Friday's After-Market Sessionbenzinga_article·Jul 31 at 09:06 PMAMIX-5.06%PFSA-7.29%
EXCLUSIVE: Medicus Pharma Launches Genomics-Guided Endometriosis Study In Abu Dhabibenzinga_article·Jul 31 at 11:15 AMMDCX+3.46%
Medicus Pharma Receives FDA “Study May Proceed” Letter for NDA-Enabling Registrational SkinJect® Study in Patients with Gorlin Syndrome | MDCX Stock NewsStockTitan·Jul 27 at 04:17 AMMDCX+3.46%
